FBXO22 and acute myeloid leukemia: Our observation demonstrated that deletion of FBXO22 significantly prevented MLL-AF9-induced AML leukemogenesis and reduced the number of LSCs in AML mice by inducing apoptosis, indicating that FBXO22 functions as an oncoprotein that critically involved in the development of AML.